Created Cauldron Foods Ltd, one the first significant UK based vegetarian food manufacturing companies in 1980.
Has wide experience in food manufacturing technology and in the development of special purpose automated machinery.
Was instrumental in developing HACCP methodology for the food industry working with CCFRA, His interest now focuses on promotion and development of appropriate technology to minimize human impact on our environment.
Formation of a commercial relationship with Purest Colloids INC, lead to the formation of purecolloids.co.uk
Even in antiquity silver was recognised, albeit anecdotally, as having antibacterial properties. Ancient romans used silver vessels, and cutlery was made in silver. In the past silver coins were placed in milk to reduce souring.
In more recent times silver in various forms has been used in bandages to aid healing and prevent infection, as well as a host of other uses such as incorporation into the surfaces of items used in kitchens and hospitals. One research document states that silver is effective against 650 strains of microorganisms. A full list of references would certainly run into several pages, here are a few examples.
This is still a hotly debated subject and more research is required, but some research suggests that it is silver Ag+ ions that have a disruptive effect on the cellular membrane leading to death of the organism.
The problem here lies in ion delivery, as ingested solutions of ionic silver become silver compounds within 7 seconds of ingestion. Silver nanoparticles can travel through the human organism whilst releasing silver ions from their surface.
This process of oxidisation is slower than the direct ionic contact method, but in the cases where free ions such as chloride may be present (blood serum etc), silver nanoparticles are an effective delivery mechanism for silver ions due to their low reactivity potential. Whether antimicrobial property derives from the actual particle or their ion releasing capacity, the result is the same.
A true colloidal silver of silver NP’s has low reactivity in the human organism, ionic solutions are highly reactive. Silver ions will combine with free chloride ions found in the human organism in about 7 seconds.
Many of the products available on the market today called colloidal silver contain low particle concentration and often of very large particle size, together with a high ionic content. A true colloid containing over 50% particles and of a mean particle size of less than 10Nm is a massively more effective in antimicrobial activity.
It may be possible, but unlikely as silver causes affected organisms to die before they can develop resistant mutations. More research is necessary, but there is much potential for the creation of therapeutic cocktails perhaps incorporating silver NP’s with other antimicrobials.
The fact that the FDA allows it to be manufactured in a highly controlled facility, and to be sold to the public, supports this. Whilst there are no specific regulations relating to colloidal silver, manufacturing facilities are rigorously controlled by the FDA as with any food or pharmaceutical related process.
A colloid is an insoluble substance suspended in another substance. Silver nanoparticles in Mesosilver™ will remain in a colloidal state indefinitely due to particle zeta potential.
In the case of some high concentration large particle colloids, potentially dangerous protein additions are required to prevent agglomeration and precipitation of particles.
Ionic silver solutions are not colloids. The silver ions (silver particles missing one outer orbital electron) can only exist in the solute. Once in contact with free ions or when the water evaporates, insoluble and sometimes undesirable silver compounds will form.
Whilst they are useful in certain external applications, ionic solutions are limited by their reactive capacity. In many cases the silver compounds formed are non-effective and/or undesirable in high dosage.
True colloids of silver nanoparticles do not suffer from this disadvantage as they do not readily form compounds in the human organism.
Particle size is crucial when silver nanoparticle reactions are concerned. The capacity of silver nanoparticles to release silver ions (Ag+) occurs only on the particle surface. Therefore, with any given particulate weight, the smaller the particle the greater the total surface area.
In addition, it has been shown that smaller particle sized NP’s demonstrate an enhanced ability to release silver ions. Even in the case where actual particle contact may prove to be the reactive mechanism, surface area is still the dominant factor in determining effectiveness.
purecolloids.co.uk offers the full range of Mesocolloid™ products manufactured by Purest Colloids INC New Jersey.
Mesosilver™ is unique in its product group, representing the smallest possible true colloidal silver suspension. Mesosilver™ has a particle concentration of 20ppm and a consistent particle size of 0.65 Nm.
This is the smallest and most effective silver colloid available anywhere. Mesosilver™ is available in 250 ml, 500 ml, 1 US gal, and 5 US gal units.
Mesosilver™ is quite simply the best true colloid silver on the market. It represents the most effective product in terms of particle size to concentration, and the best value for money.
Mesosilver™, by virtue of its high particle content (over 80%) and its particle size of 0.65 Nm at 20 ppm, is unmatched by any other manufacturer.
Whilst at present Colloidal silver is limited to being marketed as a dietary supplement its potential use in combating pathogenic organisms is significant, particularly in the light of the development of antibiotic resistant bacteria.
In addition, there is massive potential in the research into its use in anti-viral and anti-fungal uses. purecolloids.co.uk is committed to supporting the responsible use of nanoparticle silver in its various applications, and the development of safe use guidelines for colloidal silver products within the currently existing legal framework.
Sponsored Content Policy: News-Medical.net publishes articles and related content that may be derived from sources where we have existing commercial relationships, provided such content adds value to the core editorial ethos of News-Medical.Net which is to educate and inform site visitors interested in medical research, science, medical devices and treatments.
Tags: Antibiotic, Antimicrobial Resistance, Bacteria, Biosensor, Blood, Cell, Electron, Ion, Manufacturing, Medical School, Mutation, Nanoparticle, Nanoparticles, Nanotechnology, Particle Size, Protein, Research, Silver Nanoparticles, Vegetarian
Pure Colloids. (2019, November 06). Differences between colloidal silver and ionic silver solutions. News-Medical. Retrieved on March 03, 2020 from https://www.news-medical.net/news/20191106/Differences-between-colloidal-silver-and-ionic-silver-solutions.aspx.
Pure Colloids. “Differences between colloidal silver and ionic silver solutions”. News-Medical. 03 March 2020. .
Pure Colloids. “Differences between colloidal silver and ionic silver solutions”. News-Medical. https://www.news-medical.net/news/20191106/Differences-between-colloidal-silver-and-ionic-silver-solutions.aspx. (accessed March 03, 2020).
Pure Colloids. 2019. Differences between colloidal silver and ionic silver solutions. News-Medical, viewed 03 March 2020, https://www.news-medical.net/news/20191106/Differences-between-colloidal-silver-and-ionic-silver-solutions.aspx.
Researchers are in desperate need of single-cell analysis techniques and those that allow the isolation of high-value T-cells for research and development.
An interview with ZEISS, to discuss the challenges faced in neuroscience research microscopy techniques and their latest microscope.
Andrew Sewell speaks to News-Medical about his breakthrough research, in which he has discovered a new T-Cell that could treat most cancers.
News-Medical.Net provides this medical information service in accordance with these terms and conditions. Please note that medical information found on this website is designed to support, not to replace the relationship between patient and physician/doctor and the medical advice they may provide.
We use cookies to enhance your experience. By continuing to browse this site you agree to our use of cookies. More info.
Post time: Mar-03-2020